(Bloomberg) -- The federal government has awarded $7.2 billion in contracts to fight the coronavirus pandemic, including one that would pay a little-known Massachusetts biotech firm more than its reported revenue for the last three years combined.The award to Moderna Inc. is just one example of the thousands of federal contracts awarded by the Trump administration to fight the coronavirus, according to a review of federal data compiled by Bloomberg Government. Some companies have secured nine-figure deals to supply thousands of ventilators, face masks, hospital capacity and other critical services needed to manage the outbreak.Amsterdam-based Royal Philips NV has so far been the top corporate recipient with some $661.4 million in agreements. The vast majority of that sum came on April 8 via a $646.7 million contract to procure ventilators from the health technology giant’s Philips Electronics North America unit.Health and Human Services last week awarded seven contracts worth a combined...
Cummins Inc. and Tula Technology, Inc. will collaborate on a technical demonstration of diesel Dynamic Skip Fire (dDSF), which controls cylinder deactivation to reduce emissions and fuel consumption. ...
Sycamore said less than one month after entering the deal with L Brands, the company closed nearly all of its about 1,600 Victoria's Secret and PINK stores globally, including more than a thousand stores in North America. L Brands also furloughed most of its Victoria's Secret employees and reduced compensation for senior staff and took other actions that could hurt the lingerie business, Sycamore said in the filing....
U.S. drugmaker Pfizer Inc. (PFE) and BioNTech SE (BNTX) got the green light from German regulators to conduct the first in-human clinical trial in Germany of a potential coronavirus vaccine.Pfizer and BioNTech said they expected shortly to get regulatory approval to also start clinical trials in the U.S. Pfizer shares rose as much as 10% in early morning trading and were priced at $36.38 around midday. BioNtech stock surged 14% to $48.35.The Phase 1/2 trial comprises 4 vaccine candidates. The trial will include about 200 healthy individuals between the ages of 18 to 55 and aims to test the safety and immunogenicity of the vaccine. The study will also evaluate the effects of repeated immunization for three of the four vaccine candidates which utilize uRNA or modRNA. Individuals with a higher risk for a severe COVID-19 infection will be included in the second part of the study.“We are pleased to have completed pre-clinical studies...
Earning season is officially underway, with Delta Air Lines posting its first quarterly loss in over five years. Yahoo Finance’s Jared Blikre recaps the latest earnings reports from Delta Air Lines, Chipotle, and Snap....
(Bloomberg) -- Mexico is on track to cash in on a $6 billion windfall once its massive insurance program against low oil prices kicks in following a dramatic plunge in prices, President Andres Manuel Lopez Obrador said on Wednesday.For the past two decades, Mexico has locked in its oil revenue via put options it buys from a small group of investment banks and oil companies in what’s considered Wall Street’s largest -- and most closely guarded -- annual oil deal.The options give Mexico the right to sell its oil at a predetermined price. They are the equivalent of an insurance policy: the country banks all gains from a rally but enjoys the security of a minimum floor. So if oil remains weak or plunges even further, Mexico will still book higher prices.“We protected the Ministry of Finance,” Lopez Obrador said in Mexico City. “We insured an oil price of $49 a...
